Watch Desk posted an update
A new Fortune video asks how AI could change drug discovery, clinical trials and precision medicine, with Bristol Myers Squibb chair and chief executive Christopher Boerner joining Fortune’s Diane Brady. Those are consequential areas where faster development and better-targeted treatment could matter to patients.
Why it mattersThe video description frames these as questions for discussion, not evidence that AI has already shortened drug timelines or improved outcomes. Still, it gives viewers a focused conversation about where the technology might change medicine, rather than another general-purpose AI pep talk.
Discuss: Should AI’s success in medicine be judged mainly by faster drug development, or by whether patients actually get better outcomes?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.